메뉴 건너뛰기




Volumn 413, Issue 1-2, 2012, Pages 207-212

Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome

Author keywords

Acute coronary syndrome; Biomarkers; Lysophosphatidic acid; Plaque rupture; Thrombosis

Indexed keywords

AUTOTAXIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE; OXIDIZED LOW DENSITY LIPOPROTEIN;

EID: 82955187784     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.09.027     Document Type: Article
Times cited : (44)

References (34)
  • 1
    • 15344341231 scopus 로고    scopus 로고
    • Thrombogenic and atherogenic activities of lysophosphatidic acid
    • Siess W., Tigyi G. Thrombogenic and atherogenic activities of lysophosphatidic acid. J Cell Biochem 2004, 92:1086-1094.
    • (2004) J Cell Biochem , vol.92 , pp. 1086-1094
    • Siess, W.1    Tigyi, G.2
  • 2
    • 33746617364 scopus 로고    scopus 로고
    • Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein
    • Siess W. Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein. Pathophysiol Haemost Thromb 2006, 35:292-304.
    • (2006) Pathophysiol Haemost Thromb , vol.35 , pp. 292-304
    • Siess, W.1
  • 3
    • 70349776386 scopus 로고    scopus 로고
    • Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation
    • Morris A.J., Selim S., Salous A., Smyth S.S. Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation. Trends Cardiovasc Med 2009, 19:135-140.
    • (2009) Trends Cardiovasc Med , vol.19 , pp. 135-140
    • Morris, A.J.1    Selim, S.2    Salous, A.3    Smyth, S.S.4
  • 4
    • 0037073806 scopus 로고    scopus 로고
    • Serum lysophosphatidic acid is produced through diverse phospholipase pathways
    • Aoki J., Taira A., Takanezawa Y., et al. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 2002, 277:48737-48744.
    • (2002) J Biol Chem , vol.277 , pp. 48737-48744
    • Aoki, J.1    Taira, A.2    Takanezawa, Y.3
  • 5
    • 0033536049 scopus 로고    scopus 로고
    • Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
    • Siess W., Zangl K.J., Essler M., et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 1999, 96:6931-6936.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 6931-6936
    • Siess, W.1    Zangl, K.J.2    Essler, M.3
  • 6
    • 0043020630 scopus 로고    scopus 로고
    • Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques
    • Rother E., Brandl R., Baker D.L., et al. Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 2003, 108:741-747.
    • (2003) Circulation , vol.108 , pp. 741-747
    • Rother, E.1    Brandl, R.2    Baker, D.L.3
  • 7
    • 40749134619 scopus 로고    scopus 로고
    • Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway
    • Pamuklar Z., Lee J.S., Cheng H.Y., et al. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway. Arterioscler Thromb Vasc Biol 2008, 28:555-561.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , pp. 555-561
    • Pamuklar, Z.1    Lee, J.S.2    Cheng, H.Y.3
  • 8
    • 0036683314 scopus 로고    scopus 로고
    • Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids
    • Tokumura A., Sinomiya J., Kishimoto S., et al. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. Biochem J 2002, 365:617-628.
    • (2002) Biochem J , vol.365 , pp. 617-628
    • Tokumura, A.1    Sinomiya, J.2    Kishimoto, S.3
  • 9
    • 79955032212 scopus 로고    scopus 로고
    • The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation
    • Bolen A.L., Naren A.P., Yarlagadda S., et al. The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation. J Lipid Res 2011, 52:958-970.
    • (2011) J Lipid Res , vol.52 , pp. 958-970
    • Bolen, A.L.1    Naren, A.P.2    Yarlagadda, S.3
  • 10
    • 0043165018 scopus 로고    scopus 로고
    • Plaque rupture, lysophosphatidic acid, and thrombosis
    • Spector A.A. Plaque rupture, lysophosphatidic acid, and thrombosis. Circulation 2003, 108:641-643.
    • (2003) Circulation , vol.108 , pp. 641-643
    • Spector, A.A.1
  • 11
    • 38049183243 scopus 로고    scopus 로고
    • 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and
    • Antman E.M., Hand M., Armstrong P.W., et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008, 117:296-329.
    • (2008) Circulation , vol.117 , pp. 296-329
    • Antman, E.M.1    Hand, M.2    Armstrong, P.W.3
  • 12
    • 34548545280 scopus 로고    scopus 로고
    • ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with th
    • Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007, 116:e148-e304.
    • (2007) Circulation , vol.116
    • Anderson, J.L.1    Adams, C.D.2    Antman, E.M.3
  • 13
    • 65549111017 scopus 로고    scopus 로고
    • Revised equations for estimated GFR from serum creatinine in Japan
    • Matsuo S., Imai E., Horio M., et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
    • (2009) Am J Kidney Dis , vol.53 , pp. 982-992
    • Matsuo, S.1    Imai, E.2    Horio, M.3
  • 14
    • 0037505638 scopus 로고    scopus 로고
    • A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method
    • Kishimoto T., Matsuoka T., Imamura S., Mizuno K. A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method. Clin Chim Acta 2003, 333:59-67.
    • (2003) Clin Chim Acta , vol.333 , pp. 59-67
    • Kishimoto, T.1    Matsuoka, T.2    Imamura, S.3    Mizuno, K.4
  • 15
    • 34250686248 scopus 로고    scopus 로고
    • Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids
    • Nakamura K., Kishimoto T., Ohkawa R., et al. Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids. Anal Biochem 2007, 367:20-27.
    • (2007) Anal Biochem , vol.367 , pp. 20-27
    • Nakamura, K.1    Kishimoto, T.2    Ohkawa, R.3
  • 16
    • 0036629774 scopus 로고    scopus 로고
    • An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma
    • Kishimoto T., Soda Y., Matsuyama Y., Mizuno K. An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. Clin Biochem 2002, 35:411-416.
    • (2002) Clin Biochem , vol.35 , pp. 411-416
    • Kishimoto, T.1    Soda, Y.2    Matsuyama, Y.3    Mizuno, K.4
  • 17
    • 0034010934 scopus 로고    scopus 로고
    • Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity
    • Kosaka T., Yamaguchi M., Soda Y., et al. Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity. Clin Chim Acta 2000, 296:151-161.
    • (2000) Clin Chim Acta , vol.296 , pp. 151-161
    • Kosaka, T.1    Yamaguchi, M.2    Soda, Y.3
  • 18
    • 37249005340 scopus 로고    scopus 로고
    • Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation
    • Nakamura K., Igarashi K., Ide K., et al. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta 2008, 388:51-58.
    • (2008) Clin Chim Acta , vol.388 , pp. 51-58
    • Nakamura, K.1    Igarashi, K.2    Ide, K.3
  • 19
    • 0037162054 scopus 로고    scopus 로고
    • Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate
    • Siess W. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2002, 1582:204-215.
    • (2002) Biochim Biophys Acta , vol.1582 , pp. 204-215
    • Siess, W.1
  • 20
    • 77953186516 scopus 로고    scopus 로고
    • Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation
    • Bot M., Bot I., Lopez-Vales R., et al. Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol 2010, 176:3073-3084.
    • (2010) Am J Pathol , vol.176 , pp. 3073-3084
    • Bot, M.1    Bot, I.2    Lopez-Vales, R.3
  • 22
    • 80052472799 scopus 로고    scopus 로고
    • The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP (4) receptor activation and platelet function in whole blood
    • Schober L.J., Khandoga A.L., Dwivedi S., et al. The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP (4) receptor activation and platelet function in whole blood. J Thromb Thrombolysis 2011, 32:158-166.
    • (2011) J Thromb Thrombolysis , vol.32 , pp. 158-166
    • Schober, L.J.1    Khandoga, A.L.2    Dwivedi, S.3
  • 23
    • 1642512389 scopus 로고    scopus 로고
    • Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction
    • Chen X., Yang X.Y., Wang N.D., et al. Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction. Scand J Clin Lab Invest 2003, 63:497-503.
    • (2003) Scand J Clin Lab Invest , vol.63 , pp. 497-503
    • Chen, X.1    Yang, X.Y.2    Wang, N.D.3
  • 24
    • 47749147683 scopus 로고    scopus 로고
    • Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity
    • Hosogaya S., Yatomi Y., Nakamura K., et al. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity. Ann Clin Biochem 2008, 45:364-368.
    • (2008) Ann Clin Biochem , vol.45 , pp. 364-368
    • Hosogaya, S.1    Yatomi, Y.2    Nakamura, K.3
  • 25
    • 46749147203 scopus 로고    scopus 로고
    • Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases
    • Gendaszewska-Darmach E. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases. Acta Biochim Pol 2008, 55:227-240.
    • (2008) Acta Biochim Pol , vol.55 , pp. 227-240
    • Gendaszewska-Darmach, E.1
  • 26
    • 0037197780 scopus 로고    scopus 로고
    • Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies
    • Burke A.P., Tracy R.P., Kolodgie F., et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002, 105:2019-2023.
    • (2002) Circulation , vol.105 , pp. 2019-2023
    • Burke, A.P.1    Tracy, R.P.2    Kolodgie, F.3
  • 27
    • 0343852114 scopus 로고    scopus 로고
    • Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions
    • Hakkinen T., Luoma J.S., Hiltunen M.O., et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999, 19:2909-2917.
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 2909-2917
    • Hakkinen, T.1    Luoma, J.S.2    Hiltunen, M.O.3
  • 28
    • 33644830673 scopus 로고    scopus 로고
    • Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans
    • Yang E.H., McConnell J.P., Lennon R.J., et al. Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol 2006, 26:106-111.
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 106-111
    • Yang, E.H.1    McConnell, J.P.2    Lennon, R.J.3
  • 29
    • 30944447092 scopus 로고    scopus 로고
    • Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis
    • Kougias P., Chai H., Lin P.H., Lumsden A.B., Yao Q., Chen C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 2006, 12:RA5-RA16.
    • (2006) Med Sci Monit , vol.12
    • Kougias, P.1    Chai, H.2    Lin, P.H.3    Lumsden, A.B.4    Yao, Q.5    Chen, C.6
  • 30
    • 0036119155 scopus 로고    scopus 로고
    • Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism
    • Takahashi M., Okazaki H., Ogata Y., Takeuchi K., Ikeda U., Shimada K. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis 2002, 161:387-394.
    • (2002) Atherosclerosis , vol.161 , pp. 387-394
    • Takahashi, M.1    Okazaki, H.2    Ogata, Y.3    Takeuchi, K.4    Ikeda, U.5    Shimada, K.6
  • 31
    • 0033867025 scopus 로고    scopus 로고
    • Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL
    • Hsieh C.C., Yen M.H., Liu H.W., Lau Y.T. Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL. Atherosclerosis 2000, 151:481-491.
    • (2000) Atherosclerosis , vol.151 , pp. 481-491
    • Hsieh, C.C.1    Yen, M.H.2    Liu, H.W.3    Lau, Y.T.4
  • 32
    • 34249701265 scopus 로고    scopus 로고
    • Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans
    • Lavi S., McConnell J.P., Rihal C.S., et al. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 2007, 115:2715-2721.
    • (2007) Circulation , vol.115 , pp. 2715-2721
    • Lavi, S.1    McConnell, J.P.2    Rihal, C.S.3
  • 33
    • 14144256273 scopus 로고    scopus 로고
    • Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up
    • Brilakis E.S., McConnell J.P., Lennon R.J., Elesber A.A., Meyer J.G., Berger P.B. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up. Eur Heart J 2005, 26:137-144.
    • (2005) Eur Heart J , vol.26 , pp. 137-144
    • Brilakis, E.S.1    McConnell, J.P.2    Lennon, R.J.3    Elesber, A.A.4    Meyer, J.G.5    Berger, P.B.6
  • 34
    • 79955596968 scopus 로고    scopus 로고
    • Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium
    • Zhou Z., Subramanian P., Sevilmis G., et al. Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab 2011, 13:592-600.
    • (2011) Cell Metab , vol.13 , pp. 592-600
    • Zhou, Z.1    Subramanian, P.2    Sevilmis, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.